HighTower Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,000
Closed -$1.74K 3940
2024
Q3
$1.74K Buy
+1,000
New +$159K ﹤0.01% 3641
2022
Q3
Sell
-100
Closed -$1K 3273
2022
Q2
$1K Buy
+100
New +$17.8K ﹤0.01% 3187
2021
Q3
Sell
-100
Closed -$11K 3305
2021
Q2
$11K Buy
+100
New +$16.6K ﹤0.01% 2993
2021
Q1
Sell
-566
Closed -$238K 3161
2020
Q4
$238K Sell
566
-2,134
-79% -$315K ﹤0.01% 2089
2020
Q3
$11K Buy
2,700
+2,600
+2,600% +$385K ﹤0.01% 2416
2020
Q2
$8K Buy
+100
New +$14.6K ﹤0.01% 2325
2019
Q3
Sell
-1,400
Closed -$3K 2479
2019
Q2
$3K Buy
+1,400
New +$194K ﹤0.01% 2341
2014
Q2
Sell
-600
Closed -$3K 1661
2014
Q1
$3K Buy
+600
New +$55.6K ﹤0.01% 1550
2013
Q4
Sell
-36,231,441
Closed -$31.4M 1584
2013
Q3
$31.4M Buy
+36,231,441
New +$3.25B 0.79% 18

Other funds holding JNJ

HighTower Advisors's JNJ Position: Q1 2026 in Review

HighTower Advisors increased its Johnson & Johnson (JNJ) stake by 166% in Q1 2026, buying an estimated $1.52B and bringing the position to 10,484,201 shares worth $2.56B. The position accounts for 2.72% of the portfolio, ranked #2.

HighTower Advisors first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • HighTower Advisors held 10,484,201 shares of Johnson & Johnson worth $2.56B as of Q1 2026.
  • HighTower Advisors bought 6,535,453 Johnson & Johnson shares in Q1 2026, an estimated $1.52B.
  • Johnson & Johnson made up 2.72% of HighTower Advisors's portfolio in Q1 2026, its #2 holding.
  • HighTower Advisors first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.